Post-Hyaluronidase Syndrome: What Happens to Your Face After Filler Dissolving
Post-Hyaluronidase Syndrome: What Happens to Your Face After Filler Dissolving [...]
By Dr. Jane Yoo|2026-06-19T17:47:04+00:00June 18th, 2026|Categories: Aesthetic Innovations|Tags: after filler dissolving, dissolve filler face, filler dissolving hyaluronidase, filler reversal, hyaluronic acid filler, hyaluronidase side effects, post-hyaluronidase syndrome, ultrasound-guided filler dissolving|Comments Off on Post-Hyaluronidase Syndrome: What Happens to Your Face After Filler Dissolving
Fear of Overfilling: What Patients Want From Injectables in 2026
Fear of Overfilling: What Patients Want From Injectables in 2026 [...]
By Dr. Jane Yoo|2026-06-19T17:50:42+00:00June 18th, 2026|Categories: Aesthetic Innovations|Tags: cosmetic dermatology, facial balancing, fear of overfilling, filler dissolving, filler trends 2026, hyaluronidase, injectable minimalism, natural filler results, overfilled face|Comments Off on Fear of Overfilling: What Patients Want From Injectables in 2026
GLP-1 / Ozempic Face: A Dermatologist’s Complete Guide
GLP-1 / Ozempic Face: A Dermatologist’s Complete Guide What Is [...]
By Dr. Jane Yoo|2026-06-19T17:47:53+00:00June 18th, 2026|Categories: Social Media Trends|Tags: cosmetic dermatology, facial volume loss weight loss, filler Ozempic face, GLP-1 skin, Ozempic Face, semaglutide skin changes, skin laxity GLP-1, tirzepatide face|Comments Off on GLP-1 / Ozempic Face: A Dermatologist’s Complete Guide
Which U.S. Sunscreens Will Have Bemotrizinol First, and What to Look For on the Label
Which U.S. Sunscreens Will Have Bemotrizinol First, and What to [...]
By Dr. Jane Yoo|2026-06-19T17:48:23+00:00June 18th, 2026|Categories: Sun Protection|Tags: bemotrizinol products, bemotrizinol sunscreen US, BEMT, best sunscreen 2026, chemical sunscreen, FDA sunscreen approval, PARSOL Shield, Tinosorb S, UVA sunscreen|Comments Off on Which U.S. Sunscreens Will Have Bemotrizinol First, and What to Look For on the Label
The New Sunscreen Ingredient That Was Blocked for 25 Years, and Why It Matters Most for Skin of Color
The New Sunscreen Ingredient That Was Blocked for 25 Years, [...]
By Dr. Jane Yoo|2026-06-19T17:49:02+00:00June 18th, 2026|Categories: Sun Protection|Tags: bemotrizinol, BEMT, hyperpigmentation, melasma, PARSOL Shield, SAFE Sunscreen Standards Act, skin cancer Black patients, sunscreen policy, sunscreen skin of color, Tinosorb S, UVA protection gap|Comments Off on The New Sunscreen Ingredient That Was Blocked for 25 Years, and Why It Matters Most for Skin of Color
Bemotrizinol Is Now FDA-Approved: What It Means for Your Sunscreen
Bemotrizinol Is Now FDA-Approved: What It Means for Your Sunscreen [...]
By Dr. Jane Yoo|2026-06-19T17:49:48+00:00June 18th, 2026|Categories: Sun Protection|Tags: bemotrizinol, BEMT, broad spectrum sunscreen, FDA sunscreen approval, new sunscreen ingredient, PARSOL Shield, sunscreen 2026, Tinosorb S, UVA protection|Comments Off on Bemotrizinol Is Now FDA-Approved: What It Means for Your Sunscreen
Dr. Jane Yoo
Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York.
Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech.
Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.





